Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Harpel

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Experimental Medicine|October 1, 1977
Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulinP C Harpel
Annals of the New York Academy of Sciences|January 1, 1983
Immunoassay of alpha 2-macroglobulin-enzyme complexesP C Harpel
Annals of Epidemiology|July 1, 1992
Identification of mechanisms that may modulate the role of lipoprotein(a) in thrombosis and atherogenesisP C Harpel, W Borth
Seminars in Thrombosis and Hemostasis|January 1, 1984
Inhibitors of the fibrinolytic enzyme systemN Aoki, P C Harpel
Annals of the New York Academy of Sciences|December 4, 1992
Fibrin, lipoprotein(a), plasmin interactions: a model linking thrombosis and atherogenesisP C Harpel, W Borth
The Journal of Clinical Investigation|March 1, 1975
Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsinP C Harpel, N R Cooper
The Journal of Clinical Investigation|September 1, 1973
Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexesP C Harpel, M W Mosesson
Clinical and Experimental Immunology|September 1, 1983
C1 inactivator-C1s complexes in inflammatory joint diseaseR D Inman, P C Harpel
The Journal of Biological Chemistry|August 25, 1982
Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastaseM S Brower, P C Harpel
The Journal of Biological Chemistry|August 10, 1976
Platelet alpha2-macroglobulin and alpha1-antitrypsinR L Nachman, P C Harpel
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Experimental Medicine|October 1, 1977
Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulinP C Harpel
Annals of the New York Academy of Sciences|January 1, 1983
Immunoassay of alpha 2-macroglobulin-enzyme complexesP C Harpel
Annals of Epidemiology|July 1, 1992
Identification of mechanisms that may modulate the role of lipoprotein(a) in thrombosis and atherogenesisP C Harpel, W Borth
Seminars in Thrombosis and Hemostasis|January 1, 1984
Inhibitors of the fibrinolytic enzyme systemN Aoki, P C Harpel
Annals of the New York Academy of Sciences|December 4, 1992
Fibrin, lipoprotein(a), plasmin interactions: a model linking thrombosis and atherogenesisP C Harpel, W Borth
The Journal of Clinical Investigation|March 1, 1975
Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsinP C Harpel, N R Cooper
The Journal of Clinical Investigation|September 1, 1973
Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexesP C Harpel, M W Mosesson
Clinical and Experimental Immunology|September 1, 1983
C1 inactivator-C1s complexes in inflammatory joint diseaseR D Inman, P C Harpel
The Journal of Biological Chemistry|August 25, 1982
Proteolytic cleavage and inactivation of alpha 2-plasmin inhibitor and C1 inactivator by human polymorphonuclear leukocyte elastaseM S Brower, P C Harpel
The Journal of Biological Chemistry|August 10, 1976
Platelet alpha2-macroglobulin and alpha1-antitrypsinR L Nachman, P C Harpel
Pageof 9